BMC Biotechnology (May 2002)

A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time

  • Brohée D,
  • Guillaume M,
  • Remacle Cl,
  • Cauchie Ph,
  • Boudjeltia K Zouaoui,
  • Hubert JL,
  • Vanhaeverbeek M

DOI
https://doi.org/10.1186/1472-6750-2-8
Journal volume & issue
Vol. 2, no. 1
p. 8

Abstract

Read online

Abstract Background Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity. Results The correlation between ECLT and manual method is very tight : R = 0,99; p -6. The efficiency scores of the method are Conclusions The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research. It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors.